
Dr. Reddy's Laboratories Limited RDY
$ 13.53
-1.1%
Quarterly report 2022-Q1
added 06-27-2022
Dr. Reddy's Laboratories Limited Shares 2011-2026 | RDY
Annual Shares Dr. Reddy's Laboratories Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 166 M | 166 M | -52 M | -52 M | -52 M | -88 M | -88 M | 197 M | 302 M | 302 M | 211 M |
All numbers in INR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 302 M | -88 M | 92 M |
Shares of other stocks in the Biotechnology industry
| Issuer | Shares | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
33.4 M | - | 2.43 % | $ 254 M | ||
|
ARCA biopharma
ABIO
|
16.8 M | - | 1052.0 % | $ 415 M | ||
|
Aeterna Zentaris
AEZS
|
115 M | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
19.2 M | - | -0.23 % | $ 916 M | ||
|
Lipocine
LPCN
|
5.27 M | $ 7.4 | 1.23 % | $ 39 M | ||
|
I-Mab
IMAB
|
187 M | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
219 M | - | - | $ 40.3 B | ||
|
Genfit SA
GNFT
|
44.7 B | - | 2.54 % | $ 160 B | ||
|
Aileron Therapeutics
ALRN
|
17.9 M | - | 10.36 % | $ 9.8 M | ||
|
Biophytis SA
BPTS
|
118 M | - | -13.47 % | $ 169 M | ||
|
Ascendis Pharma A/S
ASND
|
54.8 M | $ 217.23 | -0.38 % | $ 5 B | ||
|
Midatech Pharma plc
MTP
|
80.5 M | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.58 M | - | -1.52 % | $ 24.7 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
46.7 M | $ 19.47 | 1.25 % | $ 910 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
45 M | - | - | $ 26.5 M | ||
|
Corbus Pharmaceuticals Holdings
CRBP
|
13.3 M | $ 8.28 | -1.84 % | $ 110 M | ||
|
Lexicon Pharmaceuticals
LXRX
|
363 M | $ 1.68 | 2.13 % | $ 610 M | ||
|
AgeX Therapeutics
AGE
|
1.08 K | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
1.24 M | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
12.1 M | - | 4.01 % | $ 150 M | ||
|
Институт стволовых клеток человека
ISKJ
|
75 M | - | - | - | ||
|
CollPlant Biotechnologies Ltd.
CLGN
|
11.5 M | $ 0.74 | 21.89 % | $ 8.48 M | ||
|
Adverum Biotechnologies
ADVM
|
19.8 M | - | - | $ 86.2 M | ||
|
Acer Therapeutics
ACER
|
15.8 M | - | 2.71 % | $ 14 M | ||
|
Advaxis
ADXS
|
6.02 M | - | -9.65 % | $ 45.9 M | ||
|
Exelixis
EXEL
|
272 M | $ 41.51 | 0.23 % | $ 11.3 B | ||
|
Avenue Therapeutics
ATXI
|
1.3 M | - | -52.27 % | $ 4.45 M | ||
|
Autolus Therapeutics plc
AUTL
|
255 M | $ 1.36 | -3.21 % | $ 347 M | ||
|
MediWound Ltd.
MDWD
|
27.2 M | $ 16.64 | -1.42 % | $ 453 M | ||
|
Mesoblast Limited
MESO
|
649 M | $ 14.31 | 2.07 % | $ 9.29 B | ||
|
Ayala Pharmaceuticals
AYLA
|
15.4 M | - | - | $ 7.46 M | ||
|
ChemoCentryx
CCXI
|
69.9 K | - | - | $ 3.74 B | ||
|
Genmab A/S
GMAB
|
630 M | $ 25.73 | 0.19 % | $ 16.5 B | ||
|
Aytu BioScience
AYTU
|
6.28 M | $ 2.61 | -0.76 % | $ 16.4 M | ||
|
Atreca
BCEL
|
38.6 M | - | -11.76 % | $ 5.79 M | ||
|
BioDelivery Sciences International
BDSI
|
99.3 M | - | -4.8 % | $ 255 M | ||
|
Aeglea BioTherapeutics
AGLE
|
78.2 M | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
186 M | - | - | $ 867 M | ||
|
BeiGene, Ltd.
BGNE
|
1.42 B | - | 0.49 % | $ 251 B | ||
|
Immatics N.V.
IMTX
|
62.9 M | $ 9.19 | -3.36 % | $ 578 M | ||
|
Bellerophon Therapeutics
BLPH
|
9.55 M | - | -74.18 % | $ 955 K | ||
|
Akero Therapeutics
AKRO
|
67.1 M | - | - | $ 3.67 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
192 M | $ 4.34 | -1.92 % | $ 832 M | ||
|
Akouos
AKUS
|
34.4 M | - | 0.23 % | $ 488 M | ||
|
AIkido Pharma
AIKI
|
6.18 M | - | 1.93 % | $ 17.4 M | ||
|
Ionis Pharmaceuticals
IONS
|
160 M | $ 69.55 | -1.75 % | $ 11.1 B | ||
|
Allakos
ALLK
|
86.8 M | - | - | $ 28.6 M | ||
|
Brickell Biotech
BBI
|
5.39 M | - | -5.38 % | $ 6.06 M | ||
|
Longeveron
LGVN
|
17.6 B | $ 0.87 | -8.8 % | $ 15.3 B | ||
|
Allena Pharmaceuticals
ALNA
|
68 M | - | 3.16 % | $ 1.9 M |